(2022). Circulating cell-free DNA (cfDNA) and extracellular vesicles (EVs) as prognostic and predictive biomarkers in patients with advanced Non-Small Cell Lung Cancer (NSCLC): the LEXOVE prospective study.
Circulating cell-free DNA (cfDNA) and extracellular vesicles (EVs) as prognostic and predictive biomarkers in patients with advanced Non-Small Cell Lung Cancer (NSCLC): the LEXOVE prospective study
GRISTINA, Valerio
2022-10-26
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Tesi dottorato VALERIO GRISTINA .pdf
Open Access dal 26/10/2023
Tipologia:
Pre-print
Dimensione
591.94 kB
Formato
Adobe PDF
|
591.94 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
